Section 32
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Series A, Early Stage, Late Stage, Pre-Seed, Series B, Growth, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Singapore, China, India, Brazil, France, Mexico, South Korea, Ireland, Netherlands, South Africa, Sweden, Israel, Chile, Argentina, Colombia
Industries Focus
- Technology
- Healthcare
- Infrastructure
- Software
- FinTech
- Artificial Intelligence
- Life Sciences
- Cybersecurity
- Quantum Computing
- Machine Learning
- Biotechnology
- Enterprise Software
- Computational Biology
- Precision Medicine
- Therapeutics
- Advanced Diagnostics
Investment Size:
5,000,000 to 10,000,000 USD
Investor Details Founded: 2017
Section 32 is a venture capital firm investing at the frontiers of technology and healthcare. Founded by Bill Maris, the team has vast experience building iconic companies. The firm's goal is to improve the human condition by accelerating the discovery, development, and distribution of important technologies and life-saving medicines. Section 32 invests across the entirety of technology and life sciences. This includes software, cybersecurity, advanced communications and computation, space, climate change-related technologies, machine learning, artificial intelligence, biotechnology, therapeutics, advanced diagnostics, precision medicine, genomics, and more.
In October 2023, Section 32 closed its fifth fund, raising $525 million to invest in companies that are pushing the boundaries in software and artificial intelligence. The fund focuses on enabling new capabilities and performance across markets including enterprise software, cybersecurity, data infrastructure, gaming, fintech, precision medicine, and computational biology. Notable portfolio companies include Coinbase, CrowdStrike, Thrive Earlier Detection, Vir Biotechnology, and Relay Therapeutics.
The firm's investment strategy emphasizes early-stage investments in healthcare and technology sectors, with a focus on software-driven businesses that improve the human condition. Section 32 has made 134 investments and 21 exits, with a minimum check size of $5 million and a maximum of $10 million. The firm has assets under management exceeding $2 billion and has invested in approximately 100 startups across various software-driven industries.
Requirements
- Innovative technologies with potential to transform industries
- Companies at the forefront of software and artificial intelligence
- Startups in biotechnology, therapeutics, advanced diagnostics, precision medicine, and related fields
- Focus on software-driven businesses in technology and healthcare sectors
- Early-stage investments
- Minimum check size of $5 million
- Maximum check size of $10 million
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Coinbase
- Celularity
- Gretel
- Owl AI
- Tollbit
- Crowdstrike
- Thrive Earlier Detection
- Vir Biotechnology
- Relay Therapeutics
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$9.95
-
$14.95
-
$19.95
-
$14.95
-
$39.95
-
$99.00
-
$195.00
-
$299.00
Claim this Investor
Are you an official representative of Section 32?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim